IASLC > International Association for the Study of Lung Cancer > Conferences & Events > Event Details
PD-L1 Assessment and Biomarkers for Immunotherapy
July 12, 2017 | Online


This one-hour webinar will address:

  • Aspects of PD-L1 IHC as a biomarker for PD1-PD-L1 axis immunotherapy;
  • The basis for its use;
  • The practical challenges faced in its development and application.
  • There will also be some discussion of other emerging biomarkers for this indication.

What you should expect to learn

 After viewing this program, attendees will:

  • Understand the basis and biology of the PD-L1 IHC biomarker;
  • Understand the issues around PD-L1 test 'harmonization';
  • Be aware of the emerging alternative or additional biomarkers in this space.

Keith Kerr
Department of Pathology
Aberdeen University Medical School
Aberdeen Royal Infirmary
Aberdeen, UK